GlassScriptPhysician profile
Patricia Scripko
NPI 1194046334
$23,474.57
in general payments reported to CMS, 2019-2025
40 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $9,166 · 2021: $12K · 2022: $303 · 2023: $202 · 2024: $23.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $9,515.65 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $6,141.46 | 2020-2021 | |
| Abbvie INC. | $4,951.92 | 2019-2023 | Ubrelvy |
| Novartis Pharmaceuticals Corporation | $481.80 | 2019-2022 | |
| Biogen, INC. | $179.79 | 2019-2022 | |
| Lilly USA, LLC | $162.56 | 2019-2020 | |
| Amgen INC. | $149.86 | 2019-2020 | |
| Genzyme Corporation | $137.20 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $131.81 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $126.03 | 2019 | |
| Alnylam Pharmaceuticals INC. | $123.70 | 2019-2022 | |
| Eisai INC. | $107.60 | 2019-2023 | |
| Acorda Therapeutics, INC | $95.80 | 2019 | |
| Emd Serono, INC. | $76.33 | 2019 | |
| Lundbeck LLC | $74.59 | 2019-2023 | Vyepti |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Scripko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.